13F Data
Security · CUSIP 55083R104

Lyell Immunopharma, Inc.

COM · institutional ownership from 13F filings
13F holders
1
Shares held
692.0K
Value held
$9.7M
New / sold out
0 / 0
Added / reduced
0 / 0
net 0 shares

13F holders by quarter

Q2 2021: 53Q3 2021: 63Q4 2021: 78Q1 2022: 80Q2 2022: 76Q3 2022: 94Q4 2022: 96Q1 2023: 100Q2 2023: 100Q3 2023: 107Q4 2023: 121Q1 2024: 128Q2 2024: 121Q3 2024: 118Q4 2024: 106Q1 2025: 113Q2 2025: 6Q3 2025: 2Q4 2025: 1Q1 2026: 1Q2 2026: 1
Q2 2021Q2 2026

Net shares bought by existing holders

Q2 2021: 79.7MQ3 2021: 2.8MQ4 2021: 1.7MQ1 2022: 13.9MQ2 2022: 6.2MQ3 2022: 6.7MQ4 2022: 4.3MQ1 2023: 1.1MQ2 2023: 4.5MQ3 2023: 278.0KQ4 2023: 1.2MQ1 2024: 2.6MQ2 2024: -1.1MQ3 2024: -5.4MQ4 2024: 29.2MQ1 2025: 2.1MQ2 2025: -149.9MQ3 2025: -1.8MQ4 2025: 96.6KQ1 2026: 0Q2 2026: 0
Q2 2021Q2 2026

Top holders · Q2 2026

ManagerSharesValue% of portfolio
Decheng Capital LLC692,050$9.7M1.33%

Biggest buyers

Nothing to show.

Biggest sellers

Nothing to show.